Publications in collaboration with researchers from University of the Witwatersrand (28)

2021

  1. Body mass index and disease activity in chronic inflammatory rheumatic diseases: Results of the cardiovascular in rheumatology (CARMA) project

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-10

  2. Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up

    Rheumatology (Oxford, England), Vol. 60, Núm. 6, pp. 2906-2915

2020

  1. Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study

    Arthritis Care and Research, Vol. 72, Núm. 6, pp. 822-828

  2. Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country

    BMC Rheumatology, Vol. 4, Núm. 1

2019

  1. Hyperlipoproteinaemia(a) in patients with spondyloarthritis: results of the Cardiovascular in Rheumatology (CARMA) project

    Clinical and experimental rheumatology, Vol. 37, Núm. 5, pp. 774-782

  2. Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study

    Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360

  3. Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project

    Clinical and experimental rheumatology, Vol. 37, Núm. 5, pp. 731-739

2018

  1. Detection of high cardiovascular risk patients with ankylosing spondylitis based on the assessment of abdominal aortic calcium as compared to carotid ultrasound

    Arthritis Research and Therapy, Vol. 20, Núm. 1

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

  2. Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis

    Scientific Reports, Vol. 7

2016

  1. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers

    Autoimmunity Reviews, Vol. 15, Núm. 11, pp. 1013-1030

  2. Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis

    Scientific Reports, Vol. 6

  3. The framingham score and the systematic coronary risk evaluation at low cutoff values are useful surrogate markers of high-risk subclinical atherosclerosis in patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 43, Núm. 3, pp. 486-494

  4. Vitamin D receptor GATG haplotype association with atherosclerotic disease in patients with rheumatoid arthritis

    Atherosclerosis, Vol. 245, pp. 139-142

2015

  1. Atherosclerotic disease in axial spondyloarthritis: Increased frequency of carotid plaques

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 3, pp. 315-320

  2. Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: A cross-sectional study

    Arthritis Research and Therapy, Vol. 17, Núm. 1

  3. Is the homeostatic model assessment of insulin resistance a poor predictor of cardiovascular disease in rheumatoid arthritis? Comment on the Article by Giles et al

    Arthritis and Rheumatology

  4. Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis

    BioMed Research International, Vol. 2015

  5. Osteoprotegerin concentrations relate independently to established cardiovascular disease in rheumatoid arthritis

    Journal of Rheumatology, Vol. 42, Núm. 1, pp. 39-45

  6. Protective role of the interleukin 33 rs3939286 gene polymorphism in the development of subclinical atherosclerosis in rheumatoid arthritis patients

    PLoS ONE, Vol. 10, Núm. 11